No way! But... [Design Issues]

posted by Beholder  – Russia, 2019-12-06 12:36 (448 d 12:36 ago) – Posting: # 20940
Views: 3,834

(edited by Beholder on 2019-12-06 13:06)

Dear ssussu!

» At this situation, should this subject's data with one period be included in the BE assessment?

No, you could not.

» Why?

Because you need comparison between T and R for each subject. This is the aim - to compare. In your case you have either T or R (I dont know exactly which drug was taken on period 2). At least, you could use Cmax value from period 2 if the subject withdraw after Cmax was reached. AUC - no way.

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,357 posts in 4,459 threads, 1,492 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Saturday 01:12 CET (Europe/Vienna)

The way to do research is to attack the facts
at the point of greatest astonishment.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5